These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D. Tsukamoto K, Kozai Y, Ihara H, Kohda T, Mukamoto M, Tsuji T, Kozaki S. Microb Pathog; 2008 Jun; 44(6):484-93. PubMed ID: 18242046 [Abstract] [Full Text] [Related]
7. Conformational analysis of GT1B ganglioside and its interaction with botulinum neurotoxin type B: a study by molecular modeling and molecular dynamics. Venkateshwari S, Veluraja K. J Biomol Struct Dyn; 2012 Jun; 30(3):255-68. PubMed ID: 22746533 [Abstract] [Full Text] [Related]
10. Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain. Zhou Y, Singh BR. Protein Expr Purif; 2004 Mar; 34(1):8-16. PubMed ID: 14766296 [Abstract] [Full Text] [Related]
13. Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other. Atassi MZ, Taruishi M, Naqvi M, Steward LE, Aoki KR. Protein J; 2014 Jun; 33(3):278-88. PubMed ID: 24740609 [Abstract] [Full Text] [Related]
14. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner. Strotmeier J, Lee K, Völker AK, Mahrhold S, Zong Y, Zeiser J, Zhou J, Pich A, Bigalke H, Binz T, Rummel A, Jin R. Biochem J; 2010 Oct 15; 431(2):207-16. PubMed ID: 20704566 [Abstract] [Full Text] [Related]
15. Dominant antigenic peptides located at the heavy chain terminal of botulinum neurotoxin B contain receptor-binding sites for synaptotagmin II. Shi J, Bao S, Yin J, Cai K, Hou X, Xiao L, Tu W, Wang Q, Wang H. Biochem Biophys Res Commun; 2008 Sep 19; 374(2):331-5. PubMed ID: 18639519 [Abstract] [Full Text] [Related]
16. Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Rummel A, Eichner T, Weil T, Karnath T, Gutcaits A, Mahrhold S, Sandhoff K, Proia RL, Acharya KR, Bigalke H, Binz T. Proc Natl Acad Sci U S A; 2007 Jan 02; 104(1):359-64. PubMed ID: 17185412 [Abstract] [Full Text] [Related]
17. Gangliosides interact with synaptotagmin to form the high-affinity receptor complex for botulinum neurotoxin B. Flores A, Ramirez-Franco J, Desplantes R, Debreux K, Ferracci G, Wernert F, Blanchard MP, Maulet Y, Youssouf F, Sangiardi M, Iborra C, Popoff MR, Seagar M, Fantini J, Lévêque C, El Far O. Proc Natl Acad Sci U S A; 2019 Sep 03; 116(36):18098-18108. PubMed ID: 31431523 [Abstract] [Full Text] [Related]
18. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons. Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A. Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019 [Abstract] [Full Text] [Related]
19. Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. Tsukamoto K, Kohda T, Mukamoto M, Takeuchi K, Ihara H, Saito M, Kozaki S. J Biol Chem; 2005 Oct 21; 280(42):35164-71. PubMed ID: 16115873 [Abstract] [Full Text] [Related]